NO20011656D0 - Medikamentavleveringssystemer med mukosaopprinnelse og dyreanvendelser - Google Patents

Medikamentavleveringssystemer med mukosaopprinnelse og dyreanvendelser

Info

Publication number
NO20011656D0
NO20011656D0 NO20011656A NO20011656A NO20011656D0 NO 20011656 D0 NO20011656 D0 NO 20011656D0 NO 20011656 A NO20011656 A NO 20011656A NO 20011656 A NO20011656 A NO 20011656A NO 20011656 D0 NO20011656 D0 NO 20011656D0
Authority
NO
Norway
Prior art keywords
drug delivery
delivery systems
animal applications
mucosal
mucosa
Prior art date
Application number
NO20011656A
Other languages
English (en)
Other versions
NO20011656L (no
Inventor
Charles J Matson
Yen-Lane Chen
Daniel T Ruth
Luce R M Benes
Sophie G Burgaud
Francoise L R Horriere
Isabelle M L Seyler
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of NO20011656L publication Critical patent/NO20011656L/no
Publication of NO20011656D0 publication Critical patent/NO20011656D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
NO20011656A 1998-10-02 2001-04-02 Medikamentavleveringssystemer med mukosaopprinnelse og dyreanvendelser NO20011656D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10295698P 1998-10-02 1998-10-02
PCT/US1999/022967 WO2000019987A1 (en) 1998-10-02 1999-10-01 Mucosal originated drug delivery systems and animal applications

Publications (2)

Publication Number Publication Date
NO20011656L NO20011656L (no) 2001-04-02
NO20011656D0 true NO20011656D0 (no) 2001-04-02

Family

ID=22292601

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011656A NO20011656D0 (no) 1998-10-02 2001-04-02 Medikamentavleveringssystemer med mukosaopprinnelse og dyreanvendelser

Country Status (19)

Country Link
EP (1) EP1117390B1 (no)
JP (1) JP2002526403A (no)
KR (1) KR20010075528A (no)
CN (1) CN1321086A (no)
AT (1) ATE273698T1 (no)
AU (1) AU768040B2 (no)
BR (1) BR9915020A (no)
CA (1) CA2345808A1 (no)
CZ (1) CZ20011188A3 (no)
DE (1) DE69919554T2 (no)
ES (1) ES2228125T3 (no)
HU (1) HUP0103543A2 (no)
IL (1) IL142168A0 (no)
MX (1) MXPA01003310A (no)
NO (1) NO20011656D0 (no)
NZ (1) NZ510771A (no)
PL (1) PL347061A1 (no)
PT (1) PT1117390E (no)
WO (1) WO2000019987A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331539B1 (en) 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
DE10107659B4 (de) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
AU2004278014B2 (en) 2003-10-03 2011-04-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
MXPA06005910A (es) 2003-11-25 2006-08-23 3M Innovative Properties Co Sistemas de anillo imidazo sustituido y metodos.
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
CA2597092A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
JP2006335640A (ja) * 2005-05-06 2006-12-14 Daicho Kikaku:Kk 動物用薬剤
WO2007013590A1 (ja) * 2005-07-29 2007-02-01 Santen Pharmaceutical Co., Ltd. 固形組成物を用いた後眼部組織への非侵襲性ドラッグデリバリーシステム
EP2023908A1 (en) * 2006-03-07 2009-02-18 Oramelts International, INC. Multi-layer medical patch with impermeable center
RS54764B1 (sr) * 2006-07-21 2016-10-31 Biodelivery Sciences Int Inc Sredstvo za transmukozalnu isporuku sa povećanim nakupljanjem
DE102008011800A1 (de) 2008-02-29 2009-10-15 Acino Ag Oral zerfallender Film zur therapeutischen Anwendung von Antiparasitika bei Tieren
KR101859486B1 (ko) * 2009-05-15 2018-06-28 레크로파마, 인코포레이티드 설하용 덱스메데토미딘 조성물과 그의 사용 방법
JP2012533557A (ja) * 2009-07-17 2012-12-27 ザ・ボード・オブ・リージェンツ・フォー・オクラホマ・ステート・ユニバーシティ 舌上ワクチン及びアプリケーター
EP2570217B1 (de) 2011-09-15 2014-11-05 Klingelnberg AG Semi-Completing Wälzschälverfahren und Vorrichtung mit entsprechendem Wälzschälwerkzeug zum Ausführen eines Semi-Completing Wälzschälverfahrens
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
RU2648449C2 (ru) 2013-10-07 2018-03-26 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы и композиции для трансдермальной доставки неседативного количества дексмедетомидина
EP3054935B1 (en) 2013-10-07 2020-12-09 Teikoku Pharma USA, Inc. Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
EP3054934B1 (en) * 2013-10-07 2024-05-22 Teikoku Pharma USA, Inc. Methods and compositions for treating withdrawal syndromes using non-sedative dexmedetomidine transdermal compositions
JP6188934B2 (ja) * 2013-10-07 2017-08-30 テイコク ファーマ ユーエスエー インコーポレーテッド デクスメデトミジン経皮組成物を含む疼痛管理用方法及び組成物
KR101827980B1 (ko) 2013-10-07 2018-02-13 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치 및 이의 사용 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB981372A (en) * 1960-05-04 1965-01-27 Pfizer Ltd Pharmaceutical formulations for oral administration to animals
GB1455251A (en) * 1972-08-25 1976-11-10 Evode Ltd Method of sealing gaps and compositions therefor heat
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5346701A (en) * 1993-02-22 1994-09-13 Theratech, Inc. Transmucosal delivery of macromolecular drugs
FR2712807B1 (fr) * 1993-11-24 1996-02-23 Vetoquinol Sa Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale .
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine

Also Published As

Publication number Publication date
DE69919554T2 (de) 2005-09-01
IL142168A0 (en) 2002-03-10
DE69919554D1 (de) 2004-09-23
ES2228125T3 (es) 2005-04-01
CA2345808A1 (en) 2000-04-13
KR20010075528A (ko) 2001-08-09
MXPA01003310A (es) 2003-05-15
NO20011656L (no) 2001-04-02
BR9915020A (pt) 2001-08-14
AU768040B2 (en) 2003-11-27
ATE273698T1 (de) 2004-09-15
WO2000019987A1 (en) 2000-04-13
PT1117390E (pt) 2005-01-31
CZ20011188A3 (cs) 2001-08-15
PL347061A1 (en) 2002-03-11
HUP0103543A2 (hu) 2002-01-28
JP2002526403A (ja) 2002-08-20
NZ510771A (en) 2003-08-29
EP1117390A1 (en) 2001-07-25
EP1117390B1 (en) 2004-08-18
AU1100100A (en) 2000-04-26
CN1321086A (zh) 2001-11-07

Similar Documents

Publication Publication Date Title
NO20011656D0 (no) Medikamentavleveringssystemer med mukosaopprinnelse og dyreanvendelser
EE9900481A (et) Väikesed molekulid, mida kasutatakse põletikuliste haiguste raviks
DK1212422T3 (da) Humane CTLA-4-antistoffer og anvendelserne deraf
BRPI0411924A (pt) métodos e dispositivos para oclusão de lúmens de corpo e/ou para fornecimento de agentes terapêuticos
NO20061489L (no) Formuleringer og fremgangsmater for a behandle inflamatorisk tarmsykdom
DE60041761D1 (de) Tribonektine
ATE531419T1 (de) Vorrichtung zur verabreichung von therapeutischen mitteln
NO974321D0 (no) Nodulisporsyrederivater
DK1401422T3 (da) Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf
DK1242012T3 (da) Forbedret transdermalt præventionsmiddelafgivelsessystem og fremgangsmåde
ATE337712T1 (de) Zusammensetzung zur intestinalen verabreichung
DK1082131T3 (da) Immunoregulator
IS5956A (is) Notkun bisfosónsýra til varnar og meðhöndlunar sýkingaferla
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
CA2285477A1 (en) Formulations and methods to treat and prevent equine protozoal myeloencephalitis
ATE261724T1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
DK0931082T3 (da) Nodulisporinsyrederivater
DE60033397D1 (de) Methode zur steigerung der produktionsleistung in tieren
DE60035504D1 (de) Verfahren für die verabreichung von heilmitteln mittels einer dextrinlösung
UA31156A (uk) Спосіб лікування пневмоентеритів телят
EE200200121A (et) Meetod ja süsteem teadete edastamiseks andmebaasi
WO2003028537A3 (en) Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
UA38006A (uk) Хондропротективний препарат
WO2003007800A3 (en) Methods for diagnosing and treating diseases and conditions of the digestive system and cancer
UA36485A (uk) Спосіб лікування генералізованого пародонтиту

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application